Come up with a name for your new list and we'll add to it:
CMP raised a round of funding on , . Investors include
Inventages Venture Capital.
CMP Therapeutics has developed a treatment for regulating and stimulating the immune system. The lead product is in Phase II clinical trials for allergic disorders. Other pipeline products have shown …